EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comparing criteria for objective cognitive staging in preclinical Alzheimer's disease

Kelsey K. Amon, Chao Huang, Holly H. Fleischmann, Stephen Correia, Andrew M. Kiselica

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)

DOI: 10.1002/dad2.70527 ↗
AbstractBibliografische Angaben

Abstract

Abstract INTRODUCTION Individuals with preclinical Alzheimer's disease may develop objective subtle cognitive decline (OSCD) as they transition between the cognitively unimpaired and mild cognitive impairment stages. Selection of individuals with OSCD into clinical trials may provide enrichment for participants likely to benefit from treatment. We examined how choice of operational criteria for OSCD impacted clinical staging. METHODS We analyzed data from 6154 older adults in the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease clinical trial to evaluate differences in clinical categorization rates by operational approach, as well as interactions with sex, race, and ethnicity. RESULTS: Multinomial generalized estimating equation models yielded significant differences in clinical categorization rates: Interview‐based methods led to the lowest proportion of individuals categorized with OSCD, cognitive screeners yielded the highest proportion, and multi‐test neuropsychological methods provided a balance. These main effects were moderated by significant interactions with sex and race/ethnicity. DISCUSSION Choice of OSCD criteria will have significant impacts on trial sample makeup.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →